About Double Blind Bio
Double Blind Bio automates administrative tasks, allowing clinical staff to focus on what matters most: patient care and advancing science. We’re building a future where clinical trials operate more autonomously by connecting sites, sponsors, and their data using AI. Our mission is to accelerate the delivery of cutting-edge therapeutics from development to market by building intelligent software that streamlines clinical trial operations. To date, we’ve raised over $7 million in funding from our co-lead investors, SignalFire and Define Ventures, to accelerate this vision.